Get the Stockscreener App
3.0828
4.31%
-0.1272
Hyperion Defi Inc stock is traded at $3.0828, with a volume of 114.87K.
It is down -4.31% in the last 24 hours and down -11.22% over the past month.
Eyenovia Inc is a clinical-stage ophthalmic company developing a pipeline of therapeutics based on its proprietary array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Optejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance, and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies that target new indications or New combinations.
See More
Previous Close:
$3.21
Open:
$3.12
24h Volume:
114.87K
Relative Volume:
0.34
Market Cap:
$26.27M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.54%
1M Performance:
-11.22%
6M Performance:
-49.97%
1Y Performance:
+0.00%
1-Day Range:
$3.02
$3.25
1-Week Range:
$2.761
$3.355
52-Week Range:
$2.761
$16.12
Hyperion Defi Inc Stock (HYPD) Company Profile
Name
Hyperion Defi Inc
Sector
Industry
Phone
833-393-6684
Address
295 MADISON AVENUE, NEW YORK
Compare HYPD vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HYPD
Hyperion Defi Inc
|
3.10 | 27.20M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.70 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
762.45 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
721.77 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.03 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
291.37 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Hyperion Defi Inc Stock (HYPD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-24-25 | Initiated | Chardan Capital Markets | Buy |
| Dec-16-25 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-18-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-01-21 | Initiated | Northland Capital | Outperform |
| Feb-03-20 | Downgrade | Oppenheimer | Outperform → Perform |
Hyperion Defi Inc Stock (HYPD) Latest News
Avanza Pension reports 10.19% stake in Hyperion DeFi (NASDAQ: HYPD) - Stock Titan
HYPD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Hyperion DeFi leadership outlines conviction in next-generation financial infrastructure at NASDAQ - Traders Union
HYPD Technical Analysis & ETF Price Forecast - Intellectia AI
HYPD Should I Buy - Intellectia AI
MSN Money - MSN
Hyperion to expand options income using HYPE as collateral - 디지털투데이
Hyperion DeFi - Nasdaq
Hyperion DeFi launches institutional yield vault on Hyperliquid By Investing.com - Investing.com Nigeria
Hyperliquid treasury seeks revenue boost using HYPE holdings as options collateral - The Block
Hyperion DeFi launches institutional yield vault on Hyperliquid - Investing.com
Hyperion DeFi Announces Institutional Volatility Income Vault Built on Rysk Protocol - The Manila Times
Hyperion Defi, Inc. Announces Institutional Volatility Income Vault Built on Rysk Protocol - marketscreener.com
Hyperliquid roars past XRP, BNB with 65% rally: Why treasury companies buy the HYPE - MSN
Hyperliquid Roars Past XRP, BNB With 65% Rally: Why Treasury Companies Buy The HYPE - Benzinga
Hyperion DeFi (HYPD) Price Target Increased by 46.87% to 5.99 - Nasdaq
Hyperion DeFi Issues Letter to Shareholders - The Manila Times
Inside the first U.S. public company built around Hyperliquid DeFi - Stock Titan
Humacyte (NASDAQ:HUMAW) & Hyperion DeFi (NASDAQ:HYPD) Head to Head Analysis - Defense World
Hyperion DeFi appoints Hyunsu Jung as CEO in leadership overhaul By Investing.com - Investing.com Nigeria
Hyperion DeFi (NASDAQ:HYPD) CFO David Knox Acquires 27,950 Shares of Stock - Defense World
Hyperion DeFi Finalizes Leadership Team and Equity Conversion - TipRanks
Hyperion Defi, Inc. Appoints Robert Rubenstein as General Counsel, Effective January 6, 2026 - marketscreener.com
Hyperion DeFi appoints Hyunsu Jung as CEO to fully implement its 2026 strategic plan - Bitget
Hyperion DeFi appoints Hyunsu Jung as chief executive officer - marketscreener.com
Hyperion Defi Appoints Hyunsu Jung As Chief Executive Officer - TradingView — Track All Markets
Hyperion DeFi, Inc. Stock (HYPD) Opinions on New CEO Appointment and Stock Surge - Quiver Quantitative
Hyperion DeFi appoints Hyunsu Jung as CEO in leadership overhaul - Investing.com
Hyperion DeFi Appoints Hyunsu Jung as Chief Executive Officer - The Manila Times
DeFi firm Hyperion taps new CEO and top lawyer for 2026 digital asset plans - Stock Titan
Brokerages Set Hyperion DeFi, Inc. (NASDAQ:HYPD) Target Price at $4.58 - Defense World
Hyperion DeFi (NASDAQ:HYPD) Upgraded at Zacks Research - Defense World
Top Hyperion DeFi Insider Quietly Makes a Bold Move in the Market - TipRanks
Hyperion DeFi (NASDAQ:HYPD) Coverage Initiated at Chardan Capital - Defense World
HYPD Forecast — Price Target — Prediction for 2026 - TradingView — Track All Markets
Hyperion DeFi (HYPD) Gets a Buy from Chardan Capital - The Globe and Mail
This Hyperion DeFi Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Wednesday - Benzinga
HYPD Analyst Forecasts - Quiver Quantitative
Chardan Capital initiates Hyperion DeFi stock with Buy rating, $7.75 target - Investing.com Australia
Chardan Capital Initiates Coverage of Hyperion DeFi (HYPD) with Buy Recommendation - Nasdaq
HYPD: Chardan Capital Initiates Coverage with 'Buy' Rating | HYP - GuruFocus
Chardan Initiates Hyperion DeFi at Buy With $7.75 Price Target - marketscreener.com
Strahlman buys Hyperion DeFi (HYPD) shares worth $120,663 By Investing.com - Investing.com Australia
Hyperion DeFi shares edge higher following Kinetiq airdrop and new partnership activity - MSN
Strahlman buys Hyperion DeFi (HYPD) shares worth $120,663 - Investing.com
Hyperion Defi Inc Stock (HYPD) Financials Data
There is no financial data for Hyperion Defi Inc (HYPD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Hyperion Defi Inc Stock (HYPD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Strahlman Ellen R | Director |
Dec 29 '25 |
Buy |
3.60 |
12,112 |
43,603 |
91,161 |
| Strahlman Ellen R | Director |
Dec 29 '25 |
Buy |
3.61 |
11,856 |
42,800 |
34,869 |
| Strahlman Ellen R | Director |
Dec 26 '25 |
Buy |
3.86 |
3,601 |
13,911 |
79,049 |
| Strahlman Ellen R | Director |
Dec 26 '25 |
Buy |
3.86 |
3,311 |
12,777 |
23,013 |
| Strahlman Ellen R | Director |
Dec 18 '25 |
Buy |
3.14 |
19,702 |
61,835 |
95,150 |
| Strahlman Ellen R | Director |
Dec 18 '25 |
Buy |
3.14 |
18,742 |
58,829 |
75,448 |
| Walters Happy David | Director |
Dec 17 '25 |
Buy |
3.02 |
61,930 |
187,152 |
111,930 |
| GELTZEILER MICHAEL S | Director |
Dec 17 '25 |
Buy |
3.01 |
30,000 |
90,210 |
88,015 |
4.07%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):